Reposted by Alison Tree
Sign up for our webinar with @bursturology.bsky.social on Thursday 23 October, 09.00 to hear experts discuss the use of systemic anti-cancer treatment in metastatic prostate cancer and submit questions in advance 👇
www.natcan.org.uk/events/webin...
See you there! @alison-tree.bsky.social
www.natcan.org.uk/events/webin...
See you there! @alison-tree.bsky.social
October 17, 2025 at 8:37 AM
Sign up for our webinar with @bursturology.bsky.social on Thursday 23 October, 09.00 to hear experts discuss the use of systemic anti-cancer treatment in metastatic prostate cancer and submit questions in advance 👇
www.natcan.org.uk/events/webin...
See you there! @alison-tree.bsky.social
www.natcan.org.uk/events/webin...
See you there! @alison-tree.bsky.social
Reposted by Alison Tree
📢 The NPCA State of the Nation Report 2025 is OUT!
Find the report, supplementary documents & provider results here www.natcan.org.uk/reports/npca...
@natcan-news.bsky.social @hqip.bsky.social @prostatecanceruk.bsky.social @alison-tree.bsky.social @nhsengland.bsky.social
Please share!
Find the report, supplementary documents & provider results here www.natcan.org.uk/reports/npca...
@natcan-news.bsky.social @hqip.bsky.social @prostatecanceruk.bsky.social @alison-tree.bsky.social @nhsengland.bsky.social
Please share!
NPCA State of the Nation Report 2025 - National Cancer Audit Collaborating Centre
The aim of the National Prostate Cancer Audit (NPCA) is to evaluate the patterns of care and outcomes for patients with prostate cancer in England and Wales, and to support services to improve the qua...
www.natcan.org.uk
October 9, 2025 at 9:58 AM
📢 The NPCA State of the Nation Report 2025 is OUT!
Find the report, supplementary documents & provider results here www.natcan.org.uk/reports/npca...
@natcan-news.bsky.social @hqip.bsky.social @prostatecanceruk.bsky.social @alison-tree.bsky.social @nhsengland.bsky.social
Please share!
Find the report, supplementary documents & provider results here www.natcan.org.uk/reports/npca...
@natcan-news.bsky.social @hqip.bsky.social @prostatecanceruk.bsky.social @alison-tree.bsky.social @nhsengland.bsky.social
Please share!
Reposted by Alison Tree
New comment piece by me & colleagues in @bmj.com on the using health data for research in UK
Processes are so complex and so slow now that less research is happening and we are wasting the enormous potential of the NHS to drive innovation
www.bmj.com/content/390/...
Processes are so complex and so slow now that less research is happening and we are wasting the enormous potential of the NHS to drive innovation
www.bmj.com/content/390/...
Health research in England is grinding to a halt
Wes Streeting, the UK health and social care secretary, announced in 2024 that “the NHS is broken” against a background of ballooning waiting lists, delays in disease detection, and reduced staff prod...
www.bmj.com
July 7, 2025 at 8:31 AM
New comment piece by me & colleagues in @bmj.com on the using health data for research in UK
Processes are so complex and so slow now that less research is happening and we are wasting the enormous potential of the NHS to drive innovation
www.bmj.com/content/390/...
Processes are so complex and so slow now that less research is happening and we are wasting the enormous potential of the NHS to drive innovation
www.bmj.com/content/390/...
Reposted by Alison Tree
This review discusses the contemporary management of all stages of prostate cancer, enabling holistic individualization of treatment, and describes the promise of future research to further improve outcomes.
Open Access
acsjournals.onlinelibrary.wiley.com/doi/10.3322/...
Open Access
acsjournals.onlinelibrary.wiley.com/doi/10.3322/...
July 1, 2025 at 3:45 PM
Excited to see the MARS trial highlighted here @cihangani.bsky.social @elekta.com @mrlconsortium.bsky.social @momentumstudy.bsky.social
June 27, 2025 at 11:12 AM
Excited to see the MARS trial highlighted here @cihangani.bsky.social @elekta.com @mrlconsortium.bsky.social @momentumstudy.bsky.social
Pleasure to be at the MRI in RT symposium at USZ @mguckenberger.bsky.social Meme of the day goes to Luca Boldrini
June 27, 2025 at 11:06 AM
Pleasure to be at the MRI in RT symposium at USZ @mguckenberger.bsky.social Meme of the day goes to Luca Boldrini
Reposted by Alison Tree
We had the SABR bone and nodes workshop today. @uksabr.bsky.social in collaboration with the RCR. Lots of discussion & learning for all within the SABR MDT. Collaboration at its best. Thank you to all those that attended and especially the speakers. @alison-tree.bsky.social @pattydiezh.bsky.social
June 24, 2025 at 8:33 PM
We had the SABR bone and nodes workshop today. @uksabr.bsky.social in collaboration with the RCR. Lots of discussion & learning for all within the SABR MDT. Collaboration at its best. Thank you to all those that attended and especially the speakers. @alison-tree.bsky.social @pattydiezh.bsky.social
Reposted by Alison Tree
Happy to share our review on hypo- and ultra-hypofractionation for prostate cancer radiotherapy, just published in Seminars in Radiation Oncology
@alison-tree.bsky.social @harshanigreen.bsky.social
Full-text link:
authors.elsevier.com/a/1lFrI3lXQo...
@alison-tree.bsky.social @harshanigreen.bsky.social
Full-text link:
authors.elsevier.com/a/1lFrI3lXQo...
June 13, 2025 at 7:14 PM
Happy to share our review on hypo- and ultra-hypofractionation for prostate cancer radiotherapy, just published in Seminars in Radiation Oncology
@alison-tree.bsky.social @harshanigreen.bsky.social
Full-text link:
authors.elsevier.com/a/1lFrI3lXQo...
@alison-tree.bsky.social @harshanigreen.bsky.social
Full-text link:
authors.elsevier.com/a/1lFrI3lXQo...
Fantastic opening plenary at #UKOF25 by @charlesswanton.bsky.social Cancer initiation is not a simple matter of DNA damage from carcinogens. Forget everything you learned before!
June 12, 2025 at 1:02 PM
Fantastic opening plenary at #UKOF25 by @charlesswanton.bsky.social Cancer initiation is not a simple matter of DNA damage from carcinogens. Forget everything you learned before!
Reposted by Alison Tree
💥 Our Transformational Impact Awards are now OPEN! 💥
This call supports our larger-scale research investments covering high-quality discovery science through to translational and clinical research.
Submission deadline: 1pm, 23 September 2025
Apply now 👉 buff.ly/eCSnnCM
This call supports our larger-scale research investments covering high-quality discovery science through to translational and clinical research.
Submission deadline: 1pm, 23 September 2025
Apply now 👉 buff.ly/eCSnnCM
June 10, 2025 at 4:53 PM
💥 Our Transformational Impact Awards are now OPEN! 💥
This call supports our larger-scale research investments covering high-quality discovery science through to translational and clinical research.
Submission deadline: 1pm, 23 September 2025
Apply now 👉 buff.ly/eCSnnCM
This call supports our larger-scale research investments covering high-quality discovery science through to translational and clinical research.
Submission deadline: 1pm, 23 September 2025
Apply now 👉 buff.ly/eCSnnCM
We are looking for two exceptional consultant uro-oncologists to come and join our team in Sutton. Please see further details 👇
www.royalmarsden.nhs.uk/current-vaca...
www.royalmarsden.nhs.uk/current-vaca...
Current vacancies | The Royal Marsden
www.royalmarsden.nhs.uk
June 3, 2025 at 6:41 PM
We are looking for two exceptional consultant uro-oncologists to come and join our team in Sutton. Please see further details 👇
www.royalmarsden.nhs.uk/current-vaca...
www.royalmarsden.nhs.uk/current-vaca...
Reposted by Alison Tree
A great opportunity to work in cutting edge #clinicaltrials within a fun multidisciplinary team @notchonctrainees.bsky.social
Want to be part of shaping the future direction of RT research in the UK? An exciting opportunity has arisen to work as a research fellow within the @nihr.bsky.social RTTQA Group, based at Mount Vernon Cancer Centre.
For more info please DM us! #radonc #rtqa
www.nhsjobs.com/job/UK/Hertf...
For more info please DM us! #radonc #rtqa
www.nhsjobs.com/job/UK/Hertf...
Job vacancy: Research Fellow National Radiotherapy QA Team, East and North Hertfordshire Teaching NHS Trust, Northwood | trac.jobs
www.nhsjobs.com
June 2, 2025 at 3:32 PM
A great opportunity to work in cutting edge #clinicaltrials within a fun multidisciplinary team @notchonctrainees.bsky.social
Great news! If you have an idea for a new radiotherapy trial, please find the email below
News for UK radiotherapy community.
Pleased to say that thanks to @macmillancancer we have been able to establish #ctrad.
We plan a proposals guidance meeting on 8.7.25
If you have a new trial idea and wish to attend please contact [email protected] to register
Pleased to say that thanks to @macmillancancer we have been able to establish #ctrad.
We plan a proposals guidance meeting on 8.7.25
If you have a new trial idea and wish to attend please contact [email protected] to register
May 31, 2025 at 10:27 AM
Great news! If you have an idea for a new radiotherapy trial, please find the email below
Excited to see the HERMES trial results in print www.sciencedirect.com/science/arti...
Small trial but toxicity of 2 fractions looks promising at 24/27 Gy, no GI tox of G2 or higher out to 12 weeks @momentumstudy.bsky.social @icr.ac.uk
Small trial but toxicity of 2 fractions looks promising at 24/27 Gy, no GI tox of G2 or higher out to 12 weeks @momentumstudy.bsky.social @icr.ac.uk
HERMES: Randomised trial of 2-fraction or 5-fraction MRI-guided adaptive prostate radiotherapy
To demonstrate safety and feasibility of 2-fraction stereotactic body radiotherapy (SBRT) for prostate cancer.This single centre, non-comparative, pha…
www.sciencedirect.com
May 23, 2025 at 6:48 AM
Excited to see the HERMES trial results in print www.sciencedirect.com/science/arti...
Small trial but toxicity of 2 fractions looks promising at 24/27 Gy, no GI tox of G2 or higher out to 12 weeks @momentumstudy.bsky.social @icr.ac.uk
Small trial but toxicity of 2 fractions looks promising at 24/27 Gy, no GI tox of G2 or higher out to 12 weeks @momentumstudy.bsky.social @icr.ac.uk
What could be better than 5 days in Verona in October, learning about prostate cancer? Comprehensive multidisciplinary programme aimed at oncologists, urologists, radiologists and anyone else involved in treated prostate cancer. Spread the word!
May 21, 2025 at 4:12 PM
What could be better than 5 days in Verona in October, learning about prostate cancer? Comprehensive multidisciplinary programme aimed at oncologists, urologists, radiologists and anyone else involved in treated prostate cancer. Spread the word!
Encouraging data on safety of 5-fraction SBRT for post-prostatectomy recurrence 👇
Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy
jamanetwork.com/journals/jam...
findings suggest that post-RP SBRT is a well-tolerated alternative to Conventionally Fractionated RT
#ProstateCancer
@silkegillessen.bsky.social 🚨
jamanetwork.com/journals/jam...
findings suggest that post-RP SBRT is a well-tolerated alternative to Conventionally Fractionated RT
#ProstateCancer
@silkegillessen.bsky.social 🚨
Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy
This nonrandomized clinical trial evaluates physician-reported late toxic effects and 2-year patient-reported outcomes following post–radical prostatectomy stereotactic body radiotherapy.
jamanetwork.com
May 19, 2025 at 2:41 PM
Encouraging data on safety of 5-fraction SBRT for post-prostatectomy recurrence 👇
Don’t forget to register for the annual UK Oncology forum, which is FREE to attend. Breakout sessions covering topics including prostate cancer and radiotherapy, including Dr Ben O’Leary @icr.ac.uk, Dr Rovel Colaco, Dr Katie Spencer and Prof Stefanie Corradini oncology-forum.co.uk/register/
Register today - 2025 Oncology Forum
Use this form to register for the 2025 Oncology Forum event including all of the high profile speakers from around the world.
oncology-forum.co.uk
May 9, 2025 at 12:52 PM
Don’t forget to register for the annual UK Oncology forum, which is FREE to attend. Breakout sessions covering topics including prostate cancer and radiotherapy, including Dr Ben O’Leary @icr.ac.uk, Dr Rovel Colaco, Dr Katie Spencer and Prof Stefanie Corradini oncology-forum.co.uk/register/
Congratulations to Professor Faivre-Finn on the ESTRO Breur award, and using your platform to encourage us all to address gender inequality in academic radiation oncology 👏 #ESTRO25
May 5, 2025 at 12:39 PM
Congratulations to Professor Faivre-Finn on the ESTRO Breur award, and using your platform to encourage us all to address gender inequality in academic radiation oncology 👏 #ESTRO25
Congratulations to @montefiored.bsky.social for a great presentation of the ARISTOTLE trial 👏. Always learn a lot from an RCT, sometimes not the things you were expecting to learn #ESTRO2025
May 5, 2025 at 9:07 AM
Congratulations to @montefiored.bsky.social for a great presentation of the ARISTOTLE trial 👏. Always learn a lot from an RCT, sometimes not the things you were expecting to learn #ESTRO2025
Significant benefit to focal boost in prostate cancer out to 10 years in FLAME trial #ESTRO2025 Fifteen percent of men avoid further treatment just due to the boost 🏆
May 5, 2025 at 8:52 AM
Significant benefit to focal boost in prostate cancer out to 10 years in FLAME trial #ESTRO2025 Fifteen percent of men avoid further treatment just due to the boost 🏆
Reposted by Alison Tree
Congratulations @montefiored.bsky.social & team 👏🏽 I remember talking to you in clinic about this as a registrar. Great to see the results and the impact for patients #ESTRO25 @thelancetoncol.bsky.social
May 4, 2025 at 10:09 AM
Congratulations @montefiored.bsky.social & team 👏🏽 I remember talking to you in clinic about this as a registrar. Great to see the results and the impact for patients #ESTRO25 @thelancetoncol.bsky.social
HYPO-RT-PC 10 year data presented at #ESTRO2025. Seven fractions def non-inferior to 39 fractions, suggestion that 7 fractions might even be more likely to cure?
May 3, 2025 at 1:34 PM
HYPO-RT-PC 10 year data presented at #ESTRO2025. Seven fractions def non-inferior to 39 fractions, suggestion that 7 fractions might even be more likely to cure?
Exciting data presented in ESTRO 2025 plenary: 5 fraction adjuvant breast RT (26 Gy) at least as good (and possibly better?) than 15 fractions @icr.ac.uk #ESTRO2025
May 3, 2025 at 8:42 AM
Exciting data presented in ESTRO 2025 plenary: 5 fraction adjuvant breast RT (26 Gy) at least as good (and possibly better?) than 15 fractions @icr.ac.uk #ESTRO2025
Reposted by Alison Tree
⚠️ Another key finding of this study is that higher rates of metastatic prostate cancer were seen in regions with lower rates of prostate cancer diagnosis overall which may be linked to variation in the use of PSA testing.
April 28, 2025 at 10:21 AM
⚠️ Another key finding of this study is that higher rates of metastatic prostate cancer were seen in regions with lower rates of prostate cancer diagnosis overall which may be linked to variation in the use of PSA testing.